- Home
- EYPT vs NUS Comparison
EYPT vs NUS Comparison
Compare EYPT & NUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EYPT
- NUS
- Stock Information
- Founded
- EYPT 1987
- NUS 1984
- Country
- EYPT United States
- NUS United States
- Employees
- EYPT N/A
- NUS N/A
- Industry
- EYPT Biotechnology: Laboratory Analytical Instruments
- NUS Other Pharmaceuticals
- Sector
- EYPT Industrials
- NUS Health Care
- Exchange
- EYPT Nasdaq
- NUS Nasdaq
- Market Cap
- EYPT 741.0M
- NUS 596.0M
- IPO Year
- EYPT 2005
- NUS 1996
- Fundamental
- Price
- EYPT $13.76
- NUS $12.32
- Analyst Decision
- EYPT Strong Buy
- NUS Hold
- Analyst Count
- EYPT 6
- NUS 2
- Target Price
- EYPT $25.83
- NUS $6.88
- AVG Volume (30 Days)
- EYPT 823.7K
- NUS 467.7K
- Earning Date
- EYPT 11-06-2025
- NUS 11-06-2025
- Dividend Yield
- EYPT N/A
- NUS 1.97%
- EPS Growth
- EYPT N/A
- NUS N/A
- EPS
- EYPT N/A
- NUS 2.03
- Revenue
- EYPT $51,898,000.00
- NUS $1,626,325,000.00
- Revenue This Year
- EYPT N/A
- NUS N/A
- Revenue Next Year
- EYPT N/A
- NUS $0.98
- P/E Ratio
- EYPT N/A
- NUS $6.02
- Revenue Growth
- EYPT 2.99
- NUS N/A
- 52 Week Low
- EYPT $3.91
- NUS $5.32
- 52 Week High
- EYPT $14.42
- NUS $12.41
- Technical
- Relative Strength Index (RSI)
- EYPT 66.97
- NUS 63.81
- Support Level
- EYPT $12.88
- NUS $11.60
- Resistance Level
- EYPT $14.15
- NUS $12.10
- Average True Range (ATR)
- EYPT 0.76
- NUS 0.44
- MACD
- EYPT 0.02
- NUS -0.09
- Stochastic Oscillator
- EYPT 79.11
- NUS 95.28
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.
About NUS Nu Skin Enterprises Inc.
Nu Skin Enterprises Inc is a health and beauty direct-selling company. It has two primary product categories: beauty products and wellness products. The company develops and distributes nutritional, weight-management products, and food supplements under the Nu Skin and Pharmanex brands, respectively. The company has operations internationally, in more than 50 countries across the Americas, Europe, and the Asia-Pacific.